captopril has been researched along with Genetic Predisposition in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burch, M; Cleary, MA; Dixon, M; Footitt, EJ; Jakobs, C; Salomons, GS; Stafford, J | 1 |
Felehgari, V; Khazaie, H; Malek-Khosravi, S; Mozafari, H; Rahimi, M; Rahimi, Z; Rezaei, M; Vaisi-Raygani, A; Yari, K | 1 |
Dorrance, AM; Lewis, RW; Mills, TM | 1 |
Chen, J; Fan, X; Han, Y; Hui, R; Li, W; Liu, T; Sun, K; Wang, J; Wang, S; Wang, X; Wang, Y; Wu, H; Yang, X; Zhang, W; Zhen, Y | 1 |
MacLeod, AB; Smeda, JS; Vasdev, S | 1 |
1 trial(s) available for captopril and Genetic Predisposition
Article | Year |
---|---|
Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women.
Topics: Adult; Aged; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Mass Index; Captopril; Case-Control Studies; Double-Blind Method; Electrocardiography; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Linkage Disequilibrium; Lipids; Male; Middle Aged; Odds Ratio; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Risk Factors | 2007 |
4 other study(ies) available for captopril and Genetic Predisposition
Article | Year |
---|---|
Use of a long-chain triglyceride-restricted/medium-chain triglyceride-supplemented diet in a case of malonyl-CoA decarboxylase deficiency with cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Carboxy-Lyases; Cardiomyopathies; Carnitine; Child, Preschool; Combined Modality Therapy; Dietary Supplements; Female; Genetic Predisposition to Disease; Humans; Infant; Infant Formula; Infant Nutritional Physiological Phenomena; Infant, Newborn; Malonyl Coenzyme A; Metabolism, Inborn Errors; Methylmalonic Acid; Mutation; Nutritional Status; Phenotype; Treatment Outcome; Triglycerides | 2010 |
The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.
Topics: Albuminuria; Alleles; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Factor V; Female; Genetic Predisposition to Disease; Humans; Iran; Losartan; Male; Middle Aged; Mutation; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Treatment Outcome | 2011 |
Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Erectile Dysfunction; Genetic Predisposition to Disease; Hypertension; Male; Penile Erection; Rats; Rats, Inbred SHR; Stroke | 2002 |
The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cerebral Hemorrhage; Cerebrovascular Disorders; Genetic Predisposition to Disease; Hypertension; Male; Rats; Rats, Inbred SHR | 1997 |